|
MAZE Maze Therapeutics Inc 1842295 |
| Balance Sheet |
|
Current Assets
|
$379,779,000.00 |
|
Assets
|
$419,710,000.00 |
|
Current Liabilities
|
$21,236,000.00 |
|
Liabilities
|
$78,009,000.00 |
|
Equity
|
$341,701,000.00 |
|
Shares Out
|
49737619.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-39,113,000.00 |
|
Investing Cash Flow
|
$6,275,000.00 |
| Market Analysis |
Market Cap
|
$1,374,250,412.97 |
|
Price
|
$25.89 |
|
BVPS
|
6.87 |
|
PB
|
4.02 |
|
EPS
|
-0.45 |
|
PS
|
19.44 |
|
FCF
|
$-39,206,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:24 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:20 |
|
| Apr |
May |
Jun |
| 2026-03-25 |
-0.65 |
|
|
2026-05-12 |
-0.45 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.77 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.66 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MAZE documents filed with the SEC.
MAZE Filings
Clear
